Search Results - "M V Firsova"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Autologous haematopoietic stem cell transplantation in patients with multiple myeloma complicated by dialysis-dependent renal failure by Firsova, M V, Mendeleeva, L P, Solovev, M V, Rekhtina, I G, Pokrovskaya, O S, Urnova, E S, Soboleva, N P, Dvirnyk, V N, Klyasova, G A, Kuzmina, L A, Savchenko, V G

    Published in Terapevtic̆eskii arhiv (01-09-2020)
    “…To assess the safety and efficacy of autologous haematopoietic stem cell transplantation (auto-HSCT) in multiple myeloma (MM) patients with dialysis-dependent…”
    Get full text
    Journal Article
  2. 2

    Difficulties in diagnosis of primary AL-amyloidosis by Khyshova, V. A., Rekhtina, I. G., Firsova, M. V., Mendeleeva, L. P.

    Published in Onkogematologii͡a (10-09-2021)
    “…Objective of the study : analysis of AL-amyloidosis (AL-A) diagnostics in real clinical practice and to determine the main approaches for the earlier detection…”
    Get full text
    Journal Article
  3. 3

    Multiple myeloma with extramedullary plasmacytoma: pathogenesis and clinical case by Firsova, M. V., Risinskaya, N. V., Solovev, M. V., Obukhova, T. N., Kislitsyna, M. A., Nikulina, E. E., Yakutik, I. A., Abramova, T. V., Sudarikov, A. B., Kovrigina, A. M., Mendeleeva, L. P.

    Published in Onkogematologii͡a (06-11-2022)
    “…Background . Multiple myeloma complicated by extramedullary plasmacytoma is an unfavorable variant of the disease. It remains unknown what triggers tumor…”
    Get full text
    Journal Article
  4. 4

    MAGE-C1 gene and mage-c1 protein expression comparison in primary multiple myeloma patients by Makunina, E. A., Mendeleeva, L. P., Surin, V. L., Soloviev, M. V., Firsova, M. V., Kovrigina, A. M., Sherstnev, A. A., Gal’tseva, I. V., Davydova, Y. O., Kulikov, S. M.

    Published in Onkogematologii͡a (12-04-2022)
    “…Background. Nowadays, hematology is a dynamically developing science due to the in-depth study of the molecular mechanisms of a particular disease. A better…”
    Get full text
    Journal Article
  5. 5

    TO THE ISSUE OF PROSPECTS FOR THE IMPLEMENTATION OF THE TRANSPLANTATION PROGRAM IN THE SAMARA REGION by Benyan, A. S., Pushkin, S. Yu, Novruzbekov, M. S., Kaabak, M. M., Rzhevskaya, O. N., Gubarev, K. K., Shemakin, S. Yu, Rappoport, N. N., Firsova, M. V., Sirotko, I. I., Yaremin, B. I.

    “…06.18.2021 in the Samara regional hospital named after I. V.D. Seredavin hosted a conference "Hightech medical care for patients of the Samara region – new…”
    Get full text
    Journal Article
  6. 6

    PET/CT with 18F-fluorodeoxyglucose and 11C-methionine after autologous stem cell transplantation in multiple myeloma patients by Solovev, M V, Mendeleeva, L P, Firsova, M V, Aslanidi, I P, Mukhortova, O V, Savchenko, V G

    Published in Terapevtic̆eskii arhiv (15-07-2019)
    “…Aim: to compare the results of tumor visualization when using 18F-FDG and 11C-methionine PET/CT after auto-HSCT in MM patients. Materials and methods. A…”
    Get full text
    Journal Article
  7. 7

    Bone marrow MRI after autologous transplantation and the effect of residual tumor on progression-free survival of multiple myeloma patients by Solovev, M. V., Mendeleeva, L. P., Yatsyk, G. A., Lutsik, N. S., Firsova, M. V., Gemdzhian, E. G., Savchenko, V. G.

    Published in Onkogematologii͡a (03-01-2019)
    “…Background .  The study of influence of residual tumor mass, determined by magnetic resonance imaging (MRI), on the progression-free survival (PFS) remains an…”
    Get full text
    Journal Article
  8. 8

    MORPHOLOGICAL FEATURES OF TUMORS SUBSTRATE IN MULTIPLE MYELOMA PATIENTS COMPLICATED WITH PLASMACYTOMA by Firsova, M. V., Mendeleeva, L. P., Kovrigina, A. M., Deyneko, N. I., Soloviev, M. V., Gemdzhyan, E. G., Savchenko, V. G.

    Published in Onkogematologii͡a (12-07-2018)
    “…Objective.  To study the histological structure of bone marrow (BM) and plasmacytoma tumor substrate in patients with multiple myeloma (MM).  Materials and…”
    Get full text
    Journal Article
  9. 9

    Multiple myeloma: Maintenance therapy after autologous hematopoietic stem cell transplantation, depending on minimal residual disease by Solovyev, M V, Mendeleeva, L P, Pokrovskaya, O S, Nareyko, M V, Firsova, M V, Galtseva, I V, Davydova, Yu O, Kapranov, N M, Kuzmina, L A, Gemdzhian, E G, Savchenko, V G

    Published in Terapevtic̆eskii arhiv (2017)
    “…To determine the efficiency of maintenance therapy with bortezomib in patients with multiple myeloma (MM) who have achieved complete remission (CR) after…”
    Get full text
    Journal Article
  10. 10

    Allogeneic hematopoietic stem cell transplantation in patients with multiple myeloma by Firsova, Maiia V., Mendeleeva, Larisa P., Parovichnikova, Elena N., Solovev, Maksim V., Kuzmina, Larisa A., Risinskaya, Natalia V., Abramova, Tatiana V., Galtseva, Irina V., Savchenko, Valerii G.

    Published in Terapevtic̆eskii arhiv (23-07-2021)
    “…Aim. To analyze the effectiveness of allogeneic hematopoietic stem cell transplantation (allo-HSCT) from a related HLA-identical donor in patients with…”
    Get full text
    Journal Article
  11. 11

    Soft-tissue plasmacytomas complicates the course of multiple myeloma (clinical cases) by L P Mendeleeva, O S Pokrovskaya, M V Nareyko, D S Dubnyak, M V Firsova, I E Kostina, G A Yacik, T V Abramova, A M Kovrigina, V N Dvirnik

    “…Extramedullary lesions in multiple myeloma occur on the extension of neoplastic plasma cells outside the cortical bone. On the local tumor growth the…”
    Get full text
    Journal Article